about
Thromboangiitis obliterans (Buerger's disease)Pharmacological treatment for Buerger's diseasePharmacological treatment for Buerger's diseasePharmacological treatment for Buerger's diseaseThromboangiitis obliterans (Buerger's disease)Buerger's disease: providing integrated care2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuGastrointestinal aspects of vasculitides.Conditions presenting with symptoms of peripheral arterial diseaseThe Incidence and Prevalence of Thromboangiitis Obliterans in Taiwan: A Nationwide, Population-based Analysis of Data Collected from 2002 to 2011.Stem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger's disease.Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease.Thromoboagiitis Obliterans (TAO).The assessment and management of diabetes related lower limb problems in India-an action research approach to integrating best practice.Thoracoscopic dorsal sympathectomy for upper limb Buerger's disease.Vasospastic limb ischemia presenting acute and chronic limb ischemiaThromboangiitis obliterans.A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's DiseaseColon Ischemia Associated with Buerger's Disease: Case Report and Review of the Literature.Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practicesObstruction of the superior mesenteric artery due to emboli from the thoracic aorta in a patient with thromboangiitis obliteransBuerger's disease: a multidisciplinary diagnostic and therapeutic challengeTreatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case reportBuerger's Disease (Thromboangiitis Obliterans)- Management by Ilizarov's Technique of Horizontal Distraction. A Retrospective Study of 60 Cases.Causes, investigation and treatment of leg ulceration.Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuUpper Limb Ischemia: Clinical Experiences of Acute and Chronic Upper Limb Ischemia in a Single CenterThe Wound Healing Effects of Iloprost in Patients with Buerger's Disease: Claudication and Prevention of Major AmputationsDigital ischemia associated with cancer: results from a cohort study.Thromboangiitis obliterans (Buerger disease)The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.Association Between Three SNPs and Thromboangiitis Obliterans in Xinjiang Uyghur Population.Buerger's Disease; Any Current Advances?Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy.Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.Buerger's disease (thromboangiitis obliterans): clinical features and assessment by colour duplex ultrasound.Cell therapy in peripheral arterial disease.Corkscrew collaterals in Buerger's disease
P2860
Q21203052-15A02DC3-609D-4F5B-BFB7-C437D1E7DA3AQ24186035-76E36581-6A5B-4093-835A-05AC61645614Q24186181-5022521D-6651-4093-BE82-4148E0569268Q24198267-1E0908CA-3738-44E8-A0E1-D0F5B0718C77Q26752884-FE0D1D38-D5EB-4734-A50A-E0D7344ABA9EQ28072543-65C8699A-55DC-4531-AEDE-42F79DC7ED59Q28249469-320D41AC-46B4-42FE-B3A3-49DB97745781Q30240787-E5A8B0D6-363C-48DE-8B9C-E810CA2DC582Q30301251-818FD0FF-278E-4DFE-9DCB-E62C5A7A716DQ31117938-0D97133A-E3E7-4256-A584-014D1D47BA9CQ33372068-AFA0F79F-0616-44A3-89D3-FF1076A412D6Q33614806-1F619B4B-555F-4A1C-B3A4-79C279B9DA4DQ33618619-1BB7CF95-B0F3-4B29-8C96-698665759401Q33655432-0BCF16FB-D839-4E38-8AA7-6B3711FDD4E5Q33672175-7FC57497-20FF-443A-838B-684AD6D02E58Q33813049-96BA52DA-827A-4394-A2E1-560588B5B247Q33893309-30F45906-17C4-4632-A353-FDDFB8E3A3BFQ33901995-E4502E30-A193-4D4F-B4A2-3B2619A6D3F9Q33918225-F085D60D-48B1-4A40-A187-385C8B443C06Q33989390-32566C04-FEE5-4F4B-9A99-B01D92BD33AEQ34270009-CF9FBDAC-143B-4C79-84E5-0FA9B89D74BFQ34321209-B86DB720-F57A-4909-8D21-FC29285D2F95Q34532454-BD5F016A-1539-437A-847C-299E3E492371Q34796964-1AC6CC99-7F9A-4A11-B21A-06914AF007DDQ35090990-3A054D61-E29D-403A-889C-888EEAA6D060Q35203476-41AB605D-69F9-4A98-9CB7-C5E7E8C471DAQ35222307-4B49CCE9-D12F-4E36-9852-4FC469858C2DQ35860891-A48BF9D2-3274-45CD-AE50-E499A507E7F3Q35969152-FE3C3D3D-A95C-41C0-89B9-966E5701F182Q36022330-5975AD9F-A197-4135-BE23-AD0AAE041297Q36193597-09326301-72A9-49A5-A021-A5C46C238AB8Q36250891-6540AD2F-AE2F-46C2-B90D-89D9B8357B6FQ36380897-886528AE-0ECF-4FF2-A61E-7BFAB24327D3Q36601866-482B7D55-444B-450C-A6B1-1B39BE9CE899Q36679175-5CC36A9D-8D65-4073-92BE-C014161A84CCQ36757085-02E5BE57-E200-40B6-BDA4-F6A86F1EA13FQ37206152-1A67212F-2C56-4168-9A7D-3F0B29BF052DQ37259209-7DD01735-DA2C-4EDB-AFDF-DD41F5E610E9Q37279639-3AC13ACF-B066-4FD3-BEF1-A7AA9BD3C227Q37293757-5E01EE3F-A710-45E8-89D6-A787D209281E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Thromboangiitis obliterans (Buerger's disease).
@ast
Thromboangiitis obliterans (Buerger's disease).
@en
type
label
Thromboangiitis obliterans (Buerger's disease).
@ast
Thromboangiitis obliterans (Buerger's disease).
@en
prefLabel
Thromboangiitis obliterans (Buerger's disease).
@ast
Thromboangiitis obliterans (Buerger's disease).
@en
P1476
Thromboangiitis obliterans (Buerger's disease).
@en
P2093
P304
P356
10.1056/NEJM200009213431207
P407
P577
2000-09-01T00:00:00Z